{
  "id": 6863529,
  "title": "FERMT2 expression in human articular chondrocytes is regulated by hypoxia-associated transcriptional programs",
  "url": "https://urgent.news/2026/09/11/fermt2-expression-in-human-articular-chondrocytes-is-regulated-by",
  "topic": "science",
  "section": "Science",
  "published": "2026-09-11T00:00:00.000Z",
  "source": {
    "name": "bioRxiv",
    "slug": "biorxiv",
    "url": "https://www.biorxiv.org/content/10.64898/2026.09.05.749618v1?rss=1"
  },
  "original_language": "en",
  "account": "A recent study has uncovered a new factor influencing the regulation of kindlin-2 expression in human articular chondrocytes, a discovery that could shed light on the development of osteoarthritis. Kindlin-2, a protein encoded by the FERMT2 gene, plays a crucial role in cartilage homeostasis and mechanotransduction. In the absence of this protein in mice, the development of osteoarthritis-like pathology has been observed. However, the mechanisms governing its expression in human cartilage have remained unclear until now.\n\nResearchers employed a bioinformatics pipeline to predict transcriptional regulators of the FERMT2 promoter. This was followed by network and enrichment analyses to identify potential candidates. The predicted factors were then validated through siRNA knockdown in the human C28/I2 chondrocyte cell line and in primary osteoarthritis (OA) chondrocytes. Analysis of pathway enrichment revealed a strong connection between FERMT2 regulation and hypoxia-related regulators.\n\nTo further investigate this association, the study subjected the chondrocytes to hypoxia mimetic treatment (IOX2) and culture under low oxygen (1% O2) conditions. The results showed that FERMT2 expression was upregulated under these hypoxia conditions in both cell lines. Moreover, the expression of anabolic ECM genes increased, while catabolic enzymes were reduced, indicating a shift towards tissue-building processes. Importantly, these effects were observed independently of Kindlin-2 expression, suggesting that hypoxia has a distinct impact on FERMT2 regulation.\n\nTo further validate the role of hypoxia in FERMT2 regulation, the effects of GATA1, MEF2A, and RBPJ were tested. Knockdown of GATA1 and MEF2A was observed to reduce FERMT2 expression in both cell types, while RBPJ knockdown led to increased FERMT2 levels in both C28/I2 cells and primary OA chondrocytes. However, it is crucial to note that RBPJ silencing also resulted in decreased expression of ACAN and increased expression of COL1A1, indicating potential detrimental effects on extracellular matrix (ECM) homeostasis.\n\nIn conclusion, this study provides compelling evidence that hypoxia serves as a novel regulator of kindlin-2 expression in human cartilage. The findings offer new insights into the upstream control mechanisms governing this molecule in osteoarthritis. While other transcription factors, such as GATA1, MEF2A, and RBPJ, contribute to FERMT2 regulation, it is the hypoxia-related pathways that consistently enhance FERMT2 expression without adverse effects on ECM homeostasis. These findings open up new avenues for research and potential therapeutic strategies targeting hypoxia pathways in the context of osteoarthritis.",
  "summary": "Objective: Kindlin-2, encoded by FERMT2, is a focal adhesion protein essential for cartilage homeostasis and mechanotransduction. While loss of Kindlin-2 in mice induces osteoarthritis (OA)-like pathology, the upstream mechanisms regulating its expression in human cartilage remain unknown. Methods: A bioinformatics pipeline was applied to the FERMT2 promoter to predict transcriptional regulators,…",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}